Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2005
08/09/2005US6927056 Proteases
08/09/2005US6927044 IL-1 receptor based cytokine traps
08/09/2005US6927042 Glycoprotein synthesis
08/09/2005US6927041 Human neuropeptide Y-like G protein-coupled receptor
08/09/2005US6927040 Polpeptide for use in the treatment of granulomatosis, nervous system and skin disorders, bacterial infections and leishmania
08/09/2005US6927035 Antigens used for medical diagnosis of dihydropyrimidine dehydrogenase (DPD) deficiency
08/09/2005US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005CA2289665C Protein recovery by chromatography followed by filtration upon a charged layer
08/09/2005CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
08/09/2005CA2145400C Biotechnological method of producing biotin
08/09/2005CA2109098C Activity-dependent neurotrophic factor
08/06/2005CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof
08/04/2005WO2005070967A2 Anti-cancer antibodies with reduced complement fixation
08/04/2005WO2005070468A2 Transglutaminase mediated conjugation of peptides
08/04/2005WO2005069975A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/04/2005WO2005069970A2 Antibody specificity transfer using minimal essential binding determinants
08/04/2005WO2005069921A2 H. pylori fucosyltransferases
08/04/2005WO2005069845A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005WO2005059131A3 Protein binding miniature proteins and uses thereof
08/04/2005WO2005052001A3 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
08/04/2005WO2005045001A3 Insulin-producing cells derived from stem cells
08/04/2005WO2005044859A3 Cd20 antibodies with increased fc receptor binding affinity and effector function
08/04/2005WO2005021579A3 Epo mimetic peptides and fusion proteins
08/04/2005WO2004078953A9 Translocating enzyme used as a selection marker
08/04/2005WO2004072240A3 Antiplasmin cleaving enzyme
08/04/2005US20050172359 Using expression vector comprising phaseolin promoter to transfer and express plasma lipoprotein in seeds
08/04/2005US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders
08/04/2005US20050171343 Expression of lipoproteins
08/04/2005US20050171339 Method of stabilizing protein
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171018 Novel polypeptide and gene encoding the same
08/04/2005US20050170511 Oxa1p enhanced protein secretion
08/04/2005US20050170468 Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation
08/04/2005US20050170462 Methods and host cells for improved cell culture
08/04/2005US20050170460 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
08/04/2005US20050170457 Novel recombinant proteins with N-terminal free thiol
08/04/2005US20050170454 Cell culture medium
08/04/2005US20050170453 Modified promoter
08/04/2005US20050170452 Method to engineer mammanlian-type carbohydrate structures
08/04/2005US20050170450 Expression vector for improving transcription of exogenous gene sequences in embryonic kidney cells
08/04/2005US20050170449 Soluble GlcNAc phosphotransferase
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170424 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
08/04/2005US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker.
08/04/2005US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients
08/04/2005US20050170415 Serine protease BSSP6
08/04/2005US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures
08/04/2005US20050170407 Reagents and methods useful for detecting diseases of the lung
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170398 Producing three or more non-identical antibodies in a single recombinant host cell in which a nucleic acid sequence encoding a light chain and nucleic acid sequences encoding different heavy chains are expressed
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050170337 Nucleotide sequences coding coiled-coil viral oligomer for identifying modulator for treatment and prevention of hepatitis; viricides
08/04/2005US20050169962 Selective photopolymerization of biopolymers to create patterned structures and the patterning of cells within relatively homogenous slabs of biopolymer using dielectrophoresis; use as bioreactors, in bioassays, making artificial cartilage, or providing hepatic support
08/04/2005US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169922 drug screening for compounds that enhance or suppress killer T cell activity by contacting killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
08/04/2005US20050169911 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005CA2553883A1 Anti-cancer antibodies with reduced complement fixation
08/04/2005CA2553257A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005CA2552892A1 O-linked glycosylation of peptides
08/04/2005CA2552043A1 Transglutaminase mediated conjugation of peptides
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559789A2 Method for producing dipeptide
08/03/2005EP1559776A2 Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559712A1 A method for manufacturing optically active coumaryl amino acid salts and the coumaryl aminoacid salts thus obtained
08/03/2005EP1559328A1 Fungal feeds for aquaculture and agriculture
08/03/2005EP1559327A1 Bacterial feeds for aquaculture and agriculture
08/03/2005EP1559318A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558748A2 Cell lysis compositions, methods of use, apparatus, and kit
08/03/2005EP1558747A2 Glycoprotein synthesis
08/03/2005EP1558746A2 Nucleic acids encoding duramycin
08/03/2005EP1558729A2 Rapidly degraded reporter fusion proteins
08/03/2005EP1558725A2 High expression locus vector based on ferritin heavy chain gene locus
08/03/2005EP1558278A2 Production of homotrimeric fusion proteins
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005EP1173592B1 Microbial protein expression system
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0825259B1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650009A Modified promoter
08/03/2005CN1649894A A method for identification, isolation and production of antigens to a specific pathogen
08/03/2005CN1649623A Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
08/03/2005CN1649506A Soybean phosphopeptide calcium and method for producing thereof
08/03/2005CN1649483A ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants
08/03/2005CN1648254A Goose parvo-virus VP1 and VP3 gene non-overlapping sequence pronucleus expression protein and its preparing method
08/03/2005CN1213146C Process for producing recombinant insulin from novel fused protein
08/03/2005CN1213070C Monoclonal antibodies directed against the G3BP protein and use
08/03/2005CN1213069C Growth promoting factor and its prepn and use
08/02/2005US6924368 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis
08/02/2005US6924367 Method of modulating tissue growth using Frzb Protein
08/02/2005US6924366 Recombinant hexose oxidase, a method of producing same and use of such enzyme
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 1125